Literature for peptidase S01.231: urokinase-type plasminogen activator

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates Pharma

(References are filtered for relevance to Therapeutic. To remove the filter click here. See explanation.)

    2020
  1. Almholt,K., Wang,J., Pass,J., Roder,G., Padkjaer,S.B., Hebsgaard,J.B., Xia,W., Yang,L., Forsell,J., Breinholt,V.M., Thygesen,P., Agerso,H., Loftager,M. and Usher,P.A.
    Identification and preclinical development of an anti-proteolytic uPA antibody for rheumatoid arthritis
    J Mol Med (Berl)98, 585-593. PubMed  Europe PubMed DOI  U
  2. 2012
  3. Jakobsche,C.E., McEnaney,P.J., Zhang,A.X. and Spiegel,D.A.
    Reprogramming urokinase into an antibody-recruiting anticancer agent
    ACS Chem Biol7, 316-321. PubMed  Europe PubMed DOI  U
  4. 2006
  5. Gossage,J.A., Humphries,J., Modarai,B., Burnand,K.G. and Smith,A.
    Adenoviral urokinase-type plasminogen activator (uPA) gene transfer enhances venous thrombus resolution
    J Vasc Surg44, 1085-1090. PubMed  Europe PubMed DOI  U